CN106901153A - Sub- Ke Fen ∕ wheat bran composite powders and preparation method thereof before circle bud car - Google Patents
Sub- Ke Fen ∕ wheat bran composite powders and preparation method thereof before circle bud car Download PDFInfo
- Publication number
- CN106901153A CN106901153A CN201710156332.2A CN201710156332A CN106901153A CN 106901153 A CN106901153 A CN 106901153A CN 201710156332 A CN201710156332 A CN 201710156332A CN 106901153 A CN106901153 A CN 106901153A
- Authority
- CN
- China
- Prior art keywords
- wheat bran
- cillium
- composite powder
- circle bud
- dextrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015099 wheat brans Nutrition 0.000 title claims abstract description 66
- 239000000843 powder Substances 0.000 title claims abstract description 42
- 239000002131 composite material Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 229920001353 Dextrin Polymers 0.000 claims abstract description 29
- 239000004375 Dextrin Substances 0.000 claims abstract description 29
- 235000019425 dextrin Nutrition 0.000 claims abstract description 29
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 19
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 19
- 238000002156 mixing Methods 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims description 25
- 229940038580 oat bran Drugs 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 229920001202 Inulin Polymers 0.000 claims description 5
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 5
- 229940029339 inulin Drugs 0.000 claims description 5
- 241000209140 Triticum Species 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- 239000010903 husk Substances 0.000 claims description 3
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 2
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 2
- 240000005979 Hordeum vulgare Species 0.000 claims description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 2
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 claims description 2
- 229960000511 lactulose Drugs 0.000 claims description 2
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- 229930091371 Fructose Natural products 0.000 claims 1
- 239000005715 Fructose Substances 0.000 claims 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 8
- 230000033001 locomotion Effects 0.000 abstract description 7
- 230000036541 health Effects 0.000 abstract description 6
- 230000007413 intestinal health Effects 0.000 abstract description 6
- 241000894006 Bacteria Species 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 210000003608 fece Anatomy 0.000 abstract description 3
- 230000002349 favourable effect Effects 0.000 abstract description 2
- 239000003053 toxin Substances 0.000 abstract description 2
- 231100000765 toxin Toxicity 0.000 abstract description 2
- 230000033764 rhythmic process Effects 0.000 abstract 1
- 230000013872 defecation Effects 0.000 description 18
- 241000699666 Mus <mouse, genus> Species 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000000047 product Substances 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 239000000835 fiber Substances 0.000 description 9
- 239000000976 ink Substances 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 8
- 238000003304 gavage Methods 0.000 description 8
- 239000013642 negative control Substances 0.000 description 8
- 206010010774 Constipation Diseases 0.000 description 7
- 210000000582 semen Anatomy 0.000 description 7
- 210000000813 small intestine Anatomy 0.000 description 6
- 238000007873 sieving Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 206010000060 Abdominal distension Diseases 0.000 description 4
- 229920002774 Maltodextrin Polymers 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- -1 compound diphenoxylate Chemical class 0.000 description 3
- 229960004192 diphenoxylate Drugs 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000001809 melena Anatomy 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 235000003805 Musa ABB Group Nutrition 0.000 description 2
- 240000008790 Musa x paradisiaca Species 0.000 description 2
- 235000015266 Plantago major Nutrition 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000002011 intestinal secretion Anatomy 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 210000001187 pylorus Anatomy 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000252983 Caecum Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004534 cecum Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 231100000784 hepatotoxin Toxicity 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001141 propulsive effect Effects 0.000 description 1
- 230000001543 purgative effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Circle bud Cillium/wheat bran composite powder and preparation method thereof, belongs to food and field of health care products.Component complements each other in the present invention, synergy, increases intestinal movement, recovers the enteron aisle rhythm and pace of moving things, increases enteron stool water content, and propagation beneficial bacteria of intestinal tract group maximizes favourable factors and minimizes unfavourable ones so as to reach the multi-pronged purpose for safeguarding intestinal health.This hair is made up of circle bud Cillium, wheat bran, dextrin and oligosaccharide.The preparation method is that circle bud Cillium, dextrin and oligosaccharide are mixed, wheat bran mixing is added.Product of the present invention accelerates the effect of toxin expelling to accelerating intestinal movement, and effect is obvious, safe and reliable.
Description
Technical field
The invention belongs to food and field of health care products；Specifically related to circle bud Cillium/wheat bran composite powder and its preparation
Method.
Background technology
Increasing scientific discovery shows that intestinal health is inseparable with health.The diet structure of human body
Difference largely decide the degree of intestinal health, it is and very unreasonable in modern society's diet structure.Sugar high,
Higher fatty acid, high-cholesterol diet has had a strong impact on the general level of the health of people.What the intake of high nutrition brought is obese people ratio
Soaring, the chronic disease thus brought also gradually increases, and diabetes and angiocardiopathy crowd are growing.
High nutrition intake increased internal fat, cholesterol and triglycerides, and on the other hand low fiber causes these
Composition is easy to be piled up in enteron aisle, it is impossible to excrete out on time, so as to increased the health risk of enteron aisle, and then has influence on complete
The Nutrition and Metabolism of body.Theory of traditional Chinese medical science thinks that long-term toxin expelling does not have four big harm freely：Straining at stool gets rid of power, rectum during one hemorrhoids and constipation
Neck pressure increases, and blocks venous return, makes normal anal cushions congested loose and distad shifts repeatedly, fibrous septum therein by
Gradually relax, until being broken and with veniplex extravasated blood, expansion, fusion, or even be mingled with tiny artery and vein fistula, eventually form hemorrhoid
Sore；Two aggravate elderly patient of the cardiovascular and cerebrovascular disease constipation with cardiovascular and cerebrovascular disease, firmly excessive during defecation, can make blood pressure liter
Height, body oxygen consumption increases, it is easy to induce cerebral hemorrhage, angina pectoris, myocardial infarction, or even threat to life；Three form laparacele just
When secret, because straining at stool is excessive, intra-abdominal pressure increases suddenly, and internal organs such as small intestine etc. is prominent to body surface through stomach wall weakness in abdomen
Go out, laparacele can be formed；Four damage beauty prolonged constipation, and harmful substance is reabsorbed into blood, causes pachylosis, matt, are formed
Acne, pigmentation, face color spot etc..It is to realize that intestinal health is first-selection side by reasonable adjusting diet or meal supplement
Case.
The content of the invention
It is contemplated that by being directed to the purposes that this 3 points of regulation reaches regulating intestinal canal state simultaneously.Circle bud car in the present invention
Preceding sub- shell powder, wheat bran, dextrin and oligosaccharide these four components complement each other, and act synergistically, and increase intestinal movement, recover enteron aisle section
Rule, increases enteron stool water content, and propagation beneficial bacteria of intestinal tract group maximizes favourable factors and minimizes unfavourable ones so as to reach multi-pronged intestinal health of safeguarding
Purpose.
Circle bud Cillium/wheat bran composite powder in the present invention, it is characterised in that by weight percentage, the composite powder
Justify luxuriant Cillium, 5%-40% wheat bran, 0%-30% dextrin and 0%-50% oligosaccharide by 10%-80% to constitute.
Preferably：By weight percentage, the composite powder is to justify luxuriant Cillium, 10%-30% by 30%-60%
Wheat bran, 15%-30% dextrin and 15%-40% oligosaccharide composition.
More preferably：By weight percentage, the composite powder is to justify luxuriant Cillium, 8%- by 48%-50%
10% wheat bran, 20%-22% dextrin and 25%-27% oligosaccharide composition.
The particle diameter of the circle bud Cillium is 50~100 mesh.
The particle diameter of the wheat bran is 10~40 mesh.
The particle diameter of the dextrin is 80~100 mesh.
The particle diameter of the oligosaccharide is 80~100 mesh.
The wheat bran is by a kind of or wherein several in wheat bran, oat bran, rye bran, barley bran, buckwheat bran
It is mixed and processed, when wheat bran is mixture, any combination is pressed between various wheat bran.
The dextrin is a kind of or two of which the mixing in maltodextrin, resistant dextrin, when dextrin is mixture,
Any combination is pressed between various dextrin.
The oligosaccharide is for the one kind in FOS, galactooligosaccharide, xylo-oligosaccharide, inulin, lactulose or wherein
Several mixing, when oligosaccharide is mixture, presses any combination between various oligosaccharide.
The preparation method of above-mentioned circle bud Cillium/wheat bran composite powder is will circle bud Cillium, dextrin and low
Glycan mixes, and adds wheat bran mixing.
The unimpeded just eating method for the treatment of profit：One bag (5g), daily 2-3 times every time, and powder is dissolved in the water no less than 300ml
Take.
Circle bud isapgol husk (powder) also known as semen pulicariae shell powder main feature seed hull it is processed grind after, can absorb
About 50 times of expansion, soluble and insoluble fibers, ratio about 3 are included in kind shell：1,.Semen pulicariae originates in Iran and print
Degree, semen pulicariae shell powder size 80-100 meshes (mesh), powder is careful, containing more than 90% water-soluble fibre, after meeting water
50 times of expansion volume, therefore satiety can be increased, without heat is provided, calorie intake will not be made excessive.With others
Food fiber is compared, and plantain seed has high water-retaining property and bloating tendency, and defecation can be made smooth.
The powder of circle bud Cillium is too thin, and because its microstructure is destroyed serious, water imbibition is not so good as 80-100 on the contrary
Purpose powder.
It is the common effect of food fiber that defecation is smooth, but because plantain seed can especially increase the water in excrement, is made
Obtaining excrement has the flexibility of appropriateness, so just producing happy sense in defecation.Circle bud isapgol husk (powder) is described as " land glue
The king of matter ".
It is the main source of fiber that the present invention uses wheat bran, and fiber content is high, price is low, and impurity content is few in fiber, is
A kind of preferable Fibre Supplement, wheat bran can go deep into enteron aisle fold, stimulate intestinal secretion, increase intestinal movement, so as to reduce
Residence time of the food in enteron aisle；
Dextrin is made up of starch also known as maltodextrin through minuent hydrolysis, purification, spray drying, the shallow lake without free starch
Powder derivative.English abbreviation be MD. have that viscosity is big, thickening property is strong, dissolubility is good, instant capacity is good, it is carrier-mediated it is good, ferment it is small,
Moisture absorption is low, free from extraneous odour, sugariness are low, human body is easy to digest and assimilate, low-heat, low fat the features such as, be most preferable in food industry
One of basic material, and be increasingly widely applied in paper industry, daily-use chemical industry, fine chemistry industry, medical industry.
In addition to the physicochemical properties with general utility functions oligosaccharide, most noticeable physiological property is that it can be obvious
Improve microbial population ratio in enteron aisle, it is the activation and proliferation factor of enteral Bifidobacterium, can reduce and suppress enteral corrupt
The generation of material, suppresses the growth of harmful bacteria, regulating intestinal canal inner equilibrium；Trace elements iron, the absorption of calcium can be promoted and utilized,
To prevent osteoporosis；Hepatotoxin can be reduced, the organic acid of anticancer can be generated in intestines, there is significant preventing cancer function；And
Pure taste is sweet and delicious, with the adipose fragrance of class and tasty and refreshing soapy feeling.In recent years the product of FOS fashionable day,
The health-product markets such as Europe, the United States.
Wheat bran stimulates enteron aisle increase intestinal secretion in the present invention, then moisture is locked with circle bud Cillium, so as to increase
The water content of excrement is added so that defecation is more smooth；
The stimulation to enteron aisle of wheat bran can increase the motion of enteron aisle in the present invention, when reducing the stop in vivo of excrement
Between, this is also advantageously in the holding of fecal water.
Dextrin can improve the solubility property of product, improve taste and flavor, prevent product deliquescence.
The present invention treats both principal and secondary aspect of disease：Solve to supplement beneficial bacteria of intestinal tract with oligosaccharide while stool, promote prebiotic in enteron aisle
Bacterium breeds, so as to ensure the health of enteron aisle for a long time.
The phenolphthalein commonly used compared in the market or the laxative containing stimulating component, advantages of the present invention
1st, semen pulicariae shell powder and wheat bran act synergistically, and more effective wheat bran stimulates enteron aisle, accelerate intestinal movement, reduce stool
In enteral period of storage, so as to increase the water content of excrement；
Semen pulicariae shell powder shortens the effect that stool more effectively plays water conservation in the case of the enteron aisle time in wheat bran, protects
The moisture in stool is demonstrate,proved
Both synergy than it is oligomict action faster, taking can just significantly improve constipation for second day, stool it is aqueous
Amount is higher than single utilization semen pulicariae shell powder or wheat bran.
2nd, it is safe
The compound composition is mainly made up of dietary fiber component, is not absorbed by the body substantially, Small side effects.It is slow compared to other
Purgatives are safer, and pregnant woman, nursing period can be applied；
Sugar content is low, and this product uses FOS, belongs to Non-digestible sugar, it is impossible to change into monose (glucose) by human body
Absorb, therefore blood sugar blood sugar level will not be caused to fluctuate and insulin change, thus the intestinal dysfunction crowd that diabetes cause
Also can take；
3rd, short-term defaecation, long-term adjustment gut flora；
In short term by semen pulicariae shell powder and the defecating feces excretion of wheat bran, intestines are adjusted by FOS while relief of constipation
Road flora, so as to reach the target of long-term intestinal health.
4th, dependence is not produced, because it is not directed to intestinal receptor, simply the simple water content and enteron aisle for improving stool turns
Fortune time, thus the product does not have dependence, even if long-term taking is disabled and will not also aggravate that intestines are dry or situation of constipation.
Specific embodiment
Specific embodiment one：By weight percentage, circle bud Cillium/wheat bran composite powder is in present embodiment
Justify luxuriant Cillium, 9%12 mesh wheat brans, 18%100 mesh maltodextrins, 18%100 mesh FOSs by 54%100 mesh
Composition；Preparation method is to mix circle bud Cillium, resistant dextrin and FOS, add wheat bran (wheat bran be by
Wheat bran cleaning, drying, sieving are made) mixing.
Specific embodiment two：By weight percentage, circle bud Cillium/wheat bran composite powder is in present embodiment
Justify luxuriant Cillium, 10%12 mesh wheat brans, 20%100 mesh maltodextrins, 20%100 mesh FOSs by 50%100 mesh
Composition；Preparation method is to mix circle bud Cillium, resistant dextrin and FOS, adds wheat bran (wheat
Wheat bran is cleaned, dried by bran, sieving is made) mixing.
Specific embodiment three：By weight percentage, circle bud Cillium/wheat bran composite powder is in present embodiment
Justify luxuriant Cillium, 18%12 mesh wheat brans, 50%100 mesh resistant dextrins, 15%100 mesh FOSs by 17%100 mesh
Composition；Preparation method is to mix circle bud Cillium, resistant dextrin and FOS, adds wheat bran (wheat bran
Wheat bran cleaning, drying, sieving are made) mixing.
Specific embodiment four：By weight percentage, circle bud Cillium/wheat bran composite powder is in present embodiment
Justify luxuriant Cillium, 7%12 mesh oat brans, 28%100 mesh resistant dextrins, 22%100 mesh inulin by 43%100 mesh to constitute
's；Preparation method is to mix circle bud Cillium, resistant dextrin and inulin, and (oat bran is by wheat bran to add oat bran
Cleaning, drying, sieving are made) mixing.
Specific embodiment five：By weight percentage, circle bud Cillium/wheat bran composite powder is in present embodiment
Justify the group of luxuriant Cillium, 10%12 mesh oat brans, 20%100 mesh dextrin, 20%100 mesh FOSs by 50%100 mesh
Into；Preparation method is to mix circle bud Cillium, resistant dextrin and inulin, and (oat bran is by wheat to add oat bran
Bran cleaning, drying, sieving are made) mixing.
Using following verification experimental verification invention effects：
1st, animal experiment：
1.1st, experimental animal
Female mice, body weight 25-30g is randomly divided into 4 groups, respectively
1) circle bud Cillium+oligosaccharide group
2) circle bud Cillium+wheat bran group
3) wheat bran+oligosaccharide group
4) circle bud Cillium+wheat bran+dextrin+oligosaccharide group
1.2nd, dosage choice
According to human oral's recommended amounts, 2 times a day, 1 bag every time (5 grams), is calculated by this usage amount, if according to adult body
Weight 60kg is calculated, and it is 0.15g/kg.bw to convert into dosage (bw representatives are body weight, i.e. body weight).Test mice is measured
10 times of human body recommended amounts, i.e. 1.50g/kg.bw, normal water during continuously giving this composition 15d, experiment.
1.3rd, experimental technique
1.3.1, intestinal motility experiment
Take after optimum formula group mouse continuously gives test composition 15d, each group mouse fasting 16h (freely drink by period
Water).Model control group is given with optimum formula group difference gavage compound diphenoxylate 20ml/kg.bw, negative control group gavage is taken
Give isometric distilled water.
Each group animal gavage prepared Chinese ink suspension is given after 30 minutes.Cervical vertebra method is taken off after 25min and puts to death animal, taken out at once from pylorus
To the whole section of small intestine in caecum portion, traction tiling to straight line is not added with.Measure small intestine total length and by pylorus to ink motion forward position displacement,
Calculate Intestinal propulsive rate.
Ink progradation (%)=prepared Chinese ink advances length (cm)/total small intestinal length (cm) * 100%
1.3.2, mouse defecation experiment
Take after optimum formula group mouse continuously gives test composition 15d, each group mouse fasting 16h, model control group
Distinguish gavage compound diphenoxylate 20ml/kg.bw with optimum formula group is taken, negative control group gavage gives isometric distillation
Water, gives each group animal gavage prepared Chinese ink suspension after 30 minutes.Mouse is put into cage and is individually raised, normal diet feed.Observation note
Record, every mouse from gavage compound diphenoxylate to first discharge melena the time required to, and in 6h mouse stool interval and
Defecation weight.
1.4th, experimental result
Influence of 1 composition of table to Mouse Weight
As seen from Table 1, before and after gavage gives this composition of mouse 15d, compare with negative control group, model control group and
Take optimum formula group there are no significant difference.
Influence of 2 compositions of table to mouse small intestine ink marks propulsion rate
| Packet | Number of animals/only | Ink progradation/% |
| Negative control group | 10 | 67.25±6.30 |
| Model control group | 10 | 50.75±7.33 |
| Take optimum formula group | 10 | 51.65±8.29 |
As can be seen from Table 2, control group compares the reduction of small intestine ink progradation with negative control group and proves to model successfully, and
The small intestine ink progradation for taking optimum formula group is significantly improved compared to model control group, it was demonstrated that the invention effect is notable.
Influence of 3 compositions of table to mouse defecation time
| Packet | Number of animals/only | Melena time/min is arranged first |
| Negative control group | 10 | 79.9±37.0 |
| Model control group | 10 | 165.3±24.1 |
| Take optimum formula group | 10 | 137.4±13.4 |
As seen from Table 3, model control group is compared defecation time and is significantly extended with Normal group, and expression is modeled successfully.Clothes
With optimum formula group, defecation time significantly shortens compared with model control group.
Influence of 4 compositions of table to mouse stool interval
| Packet | Number of animals/only | 6h stool intervals/time |
| Negative control group | 10 | 18.5±3.5 |
| Model control group | 10 | 12.9±1.7 |
| Take optimum formula group | 10 | 16.3±4.5 |
As seen from Table 4, model control group compares the reduction of 6h stool intervals with Normal group, and has work difference, and expression is built
Mould success.Optimum formula group 6h stool intervals compared with model control group are taken to significantly improve.
Influence of 5 compositions of table to mouse defecation quality
| Animal packet | Number of animals/only | 6h defecations quality/g |
| Negative control group | 10 | 0.4170±0.0825 |
| Model control group | 10 | 0.1844±0.0735 |
| Take optimum formula group | 10 | 0.2354±0.0725 |
As seen from Table 5, model control group compares 6h defecation Mass losts with Normal group, and there were significant differences, represents
Model successfully.Optimum formula group 6h defecations quality compared with model control group is taken to dramatically increase.
1.5th, conclusion
According to《Health food is checked and assessment technique specification》, showing by zoopery, the present composition can be significantly
Increase mouse row's fecal grains, significantly shorten mouse and arrange the first grain melena time, while mouse will not be made to suffer from diarrhoea, to Mice Body
Increase again and do not make significant difference.The present composition has the effect of obvious regulating intestinal canal function.
2nd, human trial：
2.1st, experiment content：Simple circle bud Cillium product compares with of the invention；
Play key effect in 4 kinds of compositions of the formula is circle bud Cillium, wheat bran, so we select circle bud car
Preceding sub- shell powder and wheat bran are compared；
Example 1：Circle bud Cillium；
Example 2：Circle bud Cillium+wheat bran；
2.2nd, experiment number is 20 people, is randomly divided into 2 groups, the people of control group 10.
1st group to the 2nd group test personnel continuously take the product 15 days of embodiment 1,2, and 2 times a day, one bag every time.
2.3rd, test-meal process：Examination trencherman takes the sample of Isodose daily, continuously takes 15 days.Examination trencherman testing
Stopped using during journey with product influential on enteron aisle, normal diet does not change original eating habit.
2.1.5, evaluation index
1) defecation frequency：The defecation frequency calculated in one week increases or decreases situation；
2) abdominal distension is alleviated：The alleviation situation that abdominal distension is felt；
3) just shape evaluation：Using Bristol stool classification
* the first type：Many hard spheres (it is difficult to passing through)
* Second-Type：Sausage-like, but concave-convex surface
* the three type：Sausage-like, but there is slight crack on surface
* the four type：As sausage or snake, and surface is very smooth
* the five type：The smooth softening bar (easily by) of cut edge
* the six type：Thick fluffy piece of side, pasty state stool
* the seven type：It is watery, without solid block (fully liquid)
First type and Second-Type indicate constipation；3rd type and the 4th type are preferable just shapes, and especially the 4th type is most to hold
The shape of easy defecation；5th to the 7th type is then represented may diarrhoea.
2.2nd, experimental result
Above-mentioned three groups of experiments show that example 2 is than example 1 in the efficient increase by 40% of defecation frequency；Alleviate what abdominal distension was felt
Ratio improves 40%；Just shape improvement rate lifting 52%；The synergy of proof circle bud Cillium and wheat bran is than simple circle
Luxuriant Cillium is more effectively.
Claims (9)
1. luxuriant Cillium/wheat bran composite powder is justified, it is characterised in that by weight percentage, the composite powder is by 10%-
The luxuriant Cillium of 80% circle, 5%-40% wheat bran, 0%-30% dextrin and 0%-50% oligosaccharide composition.
2. it is according to claim 1 circle bud Cillium/wheat bran composite powder, it is characterised in that by weight percentage,
The composite powder is to justify luxuriant Cillium, 10%-30% wheat bran, 15%-30% dextrin and 15%-40% by 30%-60%
Oligosaccharide composition.
3. it is according to claim 1 circle bud Cillium/wheat bran composite powder, it is characterised in that by weight percentage,
The composite powder is low by the luxuriant Cillium of 48%-50% circles, 8%-10% wheat bran, 20%-22% dextrin and 25%-27%
Glycan composition.
4. it is according to claim 1 circle bud Cillium/wheat bran composite powder, it is characterised in that it is described circle bud isapgol husk
The particle diameter of powder is 50~100 mesh.
5. circle bud Cillium/wheat bran composite powder according to claim 1, it is characterised in that the particle diameter of the wheat bran is
10~40 mesh.
6. it is according to claim 1 circle bud Cillium/wheat bran composite powder, it is characterised in that the wheat bran is by wheat
A kind of in bran, oat bran, barley bran, rye bran, buckwheat bran wherein several is mixed and processed.
7. it is according to claim 1 circle bud Cillium/wheat bran composite powder, it is characterised in that the dextrin be malt paste
A kind of or two of which mixing in essence, resistant dextrin.
8. circle bud Cillium/wheat bran composite powder according to claim 1, it is characterised in that the oligosaccharide is for oligomeric
A kind of or wherein several mixing in fructose, galactooligosaccharide, xylo-oligosaccharide, inulin, lactulose.
9. the system of the luxuriant Cillium/wheat bran composite powder of circle described in any one claim in claim 1-8
Preparation Method, it is characterised in that the preparation method is to mix circle bud Cillium, dextrin and oligosaccharide, adds wheat bran and mixes
It is even.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710156332.2A CN106901153A (en) | 2017-03-16 | 2017-03-16 | Sub- Ke Fen ∕ wheat bran composite powders and preparation method thereof before circle bud car |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710156332.2A CN106901153A (en) | 2017-03-16 | 2017-03-16 | Sub- Ke Fen ∕ wheat bran composite powders and preparation method thereof before circle bud car |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106901153A true CN106901153A (en) | 2017-06-30 |
Family
ID=59187861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710156332.2A Pending CN106901153A (en) | 2017-03-16 | 2017-03-16 | Sub- Ke Fen ∕ wheat bran composite powders and preparation method thereof before circle bud car |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106901153A (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107319236A (en) * | 2017-08-18 | 2017-11-07 | 河南酵益生物科技有限公司 | A kind of fermented beverage formula using apple as raw material and preparation method thereof |
| CN108771247A (en) * | 2018-06-29 | 2018-11-09 | 山东探克生物科技股份有限公司 | A kind of edible fiber products and preparation method thereof with function of relaxing bowel |
| CN109077322A (en) * | 2018-08-30 | 2018-12-25 | 山西康惠中天医药科技有限公司 | A kind of maternal diet complete nourishing powder |
| CN109793242A (en) * | 2019-03-25 | 2019-05-24 | 杭州赛能医药科技有限公司 | A kind of high dietary-fiber composition and preparation method thereof |
| CN109938278A (en) * | 2019-03-26 | 2019-06-28 | 江苏雨润肉食品有限公司 | A kind of luxuriant Cillium dried beef of circle and preparation method thereof |
| CN110074305A (en) * | 2019-04-30 | 2019-08-02 | 成都魔卡路生物科技有限公司 | A kind of solid beverage reinforced gastrointestinal peristalsis, promote stool excretion |
| WO2020073436A1 (en) * | 2018-10-11 | 2020-04-16 | 长春健康未来医药科技有限公司 | Water-soluble fiber beverage for improving gastrointestinal environment, lubricating intestines and loosening stools, and maintaining slim and beautiful |
| CN111184172A (en) * | 2020-03-02 | 2020-05-22 | 兰州大学 | Codonopsis pilosula oligosaccharide solid beverage and preparation method thereof |
| CN111743147A (en) * | 2020-07-14 | 2020-10-09 | 周夫人(厦门)生物科技有限公司 | Prebiotics fiber powder and preparation method thereof |
| CN111990653A (en) * | 2020-09-04 | 2020-11-27 | 内蒙古蒙牛乳业（集团）股份有限公司 | Fiber powder rich in dietary fiber and preparation method thereof |
| CN113439807A (en) * | 2020-03-25 | 2021-09-28 | 广州万康保健品有限公司 | Beverage for losing weight and preparation method thereof |
| CN115777949A (en) * | 2022-11-18 | 2023-03-14 | 青岛海洋生物医药研究院股份有限公司 | Dietary fiber composition based on intestinal type characteristics of intestinal flora and preparation method and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5464644A (en) * | 1989-09-27 | 1995-11-07 | Kellogg Company | Ready-to-eat-cereal containing psyllium and use thereof for lowering cholesterol levels |
| CN102188005A (en) * | 2010-03-08 | 2011-09-21 | 邓忠元 | Compound cellulose preparation with obvious defaecation and cancer prevention functions |
| CN103960593A (en) * | 2014-05-06 | 2014-08-06 | 锦州市三清源食品开发有限公司 | Wheat bran puffed food and manufacturing method thereof |
-
2017
- 2017-03-16 CN CN201710156332.2A patent/CN106901153A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5464644A (en) * | 1989-09-27 | 1995-11-07 | Kellogg Company | Ready-to-eat-cereal containing psyllium and use thereof for lowering cholesterol levels |
| CN102188005A (en) * | 2010-03-08 | 2011-09-21 | 邓忠元 | Compound cellulose preparation with obvious defaecation and cancer prevention functions |
| CN103960593A (en) * | 2014-05-06 | 2014-08-06 | 锦州市三清源食品开发有限公司 | Wheat bran puffed food and manufacturing method thereof |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107319236A (en) * | 2017-08-18 | 2017-11-07 | 河南酵益生物科技有限公司 | A kind of fermented beverage formula using apple as raw material and preparation method thereof |
| CN108771247A (en) * | 2018-06-29 | 2018-11-09 | 山东探克生物科技股份有限公司 | A kind of edible fiber products and preparation method thereof with function of relaxing bowel |
| CN109077322A (en) * | 2018-08-30 | 2018-12-25 | 山西康惠中天医药科技有限公司 | A kind of maternal diet complete nourishing powder |
| WO2020073436A1 (en) * | 2018-10-11 | 2020-04-16 | 长春健康未来医药科技有限公司 | Water-soluble fiber beverage for improving gastrointestinal environment, lubricating intestines and loosening stools, and maintaining slim and beautiful |
| CN109793242A (en) * | 2019-03-25 | 2019-05-24 | 杭州赛能医药科技有限公司 | A kind of high dietary-fiber composition and preparation method thereof |
| CN109938278A (en) * | 2019-03-26 | 2019-06-28 | 江苏雨润肉食品有限公司 | A kind of luxuriant Cillium dried beef of circle and preparation method thereof |
| CN110074305A (en) * | 2019-04-30 | 2019-08-02 | 成都魔卡路生物科技有限公司 | A kind of solid beverage reinforced gastrointestinal peristalsis, promote stool excretion |
| CN111184172A (en) * | 2020-03-02 | 2020-05-22 | 兰州大学 | Codonopsis pilosula oligosaccharide solid beverage and preparation method thereof |
| CN113439807A (en) * | 2020-03-25 | 2021-09-28 | 广州万康保健品有限公司 | Beverage for losing weight and preparation method thereof |
| CN111743147A (en) * | 2020-07-14 | 2020-10-09 | 周夫人(厦门)生物科技有限公司 | Prebiotics fiber powder and preparation method thereof |
| CN111990653A (en) * | 2020-09-04 | 2020-11-27 | 内蒙古蒙牛乳业（集团）股份有限公司 | Fiber powder rich in dietary fiber and preparation method thereof |
| CN111990653B (en) * | 2020-09-04 | 2023-06-20 | 内蒙古蒙牛乳业（集团）股份有限公司 | Dietary fiber-rich fiber powder and preparation method thereof |
| CN115777949A (en) * | 2022-11-18 | 2023-03-14 | 青岛海洋生物医药研究院股份有限公司 | Dietary fiber composition based on intestinal type characteristics of intestinal flora and preparation method and application thereof |
| CN115777949B (en) * | 2022-11-18 | 2024-01-30 | 青岛海洋生物医药研究院股份有限公司 | Dietary fiber composition based on intestinal flora intestinal characteristics and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106901153A (en) | Sub- Ke Fen ∕ wheat bran composite powders and preparation method thereof before circle bud car | |
| CN101473953B (en) | Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application | |
| CN105211687A (en) | A kind of composition and method of making the same and purposes | |
| CN101103811A (en) | Health food capable of relaxing the bowels | |
| CN108719984B (en) | Meal replacement nutrition bar for gout population and preparation method thereof | |
| CN101606704A (en) | A kind of dietary fiber food with multiple function | |
| CN102302211B (en) | Health-care beverage | |
| CN105029447A (en) | Sea-fish oligopeptide powder containing activated probiotics | |
| CN105725219A (en) | Composition with water-soluble dietary fibers and non-water-soluble dietary fibers | |
| CN101416747A (en) | A kind of solid low-energy food that is rich in dietary fiber and preparation method thereof | |
| CN106723087A (en) | A kind of tablet containing kelp dietary fiber and preparation method thereof | |
| CN103349052A (en) | Biscuits suitable for constipated crowd and preparation method thereof | |
| CN101238893B (en) | High edible fibre chickpea nutritive powder and preparation and application thereof | |
| CN108056356A (en) | A kind of anthocyanidin solid beverage containing inulin and preparation method thereof | |
| CN107198246A (en) | A kind of health composition and a kind of health care preparation | |
| KR101722481B1 (en) | functional cereal containing sweet potato chip, broccoli granule and dietary fiber for constipation improving and manufacturing method thereof | |
| CN101822397B (en) | Compound beverage and production process thereof | |
| CN107319242A (en) | L-cn effervescent tablet for slimming and preparation method thereof | |
| CN103689748B (en) | One has adjustment intestines and stomach function, the anti-washing drink treated constipation | |
| KR20210067990A (en) | The composition for health of the intestine preparation method thereof | |
| CN102187964A (en) | Instant coarse grain porridge for treating constipation | |
| CN112617204A (en) | Arabic gum composition with bowel relaxing and constipation relieving effects | |
| CN113197305A (en) | Formula and preparation method of crude fiber composite solid food | |
| CN108245531A (en) | It is a kind of to improve gastrointestinal function, the anti-composition to treat constipation | |
| CN103181559A (en) | Nutritious food with bowel nourishing and purgation functions and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170630 |
|
| WD01 | Invention patent application deemed withdrawn after publication |